Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2026-02-25 @ 9:50 PM
Study NCT ID:
NCT00520403
Status:
COMPLETED
Last Update Posted:
2014-10-13
First Post:
2007-08-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Renal Cell Cancer | View |
Keywords: